Indication and Timing of P2Y12 Inhibitors Monotherapy After ACS – Leonardo Bolognese9 Marzo 2023Vascular dose of rivaroxaban: from evidence to practice – Marco Ferlini9 Marzo 20230Is Guided Antiplatelet Therapy Ready for Prime Time? – Davide Capodanno Redazione ATBVPost associati15 Settembre 2023SPOTLIGHT SESSION: Repurposing Anti-Diabetic Drugs: Present and Future Use of Sodium-GLucose CoTransporter-2 Inhibitors and GLP-1 Receptor Agonists: Discussion and Take Home MessagesLeggi tutto15 Settembre 2023SGLT2i in Patients with Aterothrombosis, with and without heart failure – Stephen WiviottLeggi tutto15 Settembre 2023GLP-1 RA in Patients with Obesity – Angelo AvogaroLeggi tuttoComments are closed.
